Editors-in-Chief: Amedeo Lonardo, Youfei Guan
Median time to first editorial decision: 6 days

Metabolism and Target Organ Damage

Articles

Most Recent | Most Viewed | Most Downloaded

A multimodal neuroimaging and hepatic imaging analysis for hepatic-type and neurological-type Wilson’s disease

Open Access Original Article DOI: 10.20517/mtod.2025.173 24 Dec 2025
Views: Downloads:
Download PDF

Accelerated biological aging drives the progression from MASLD to cirrhosis

Open Access Original Article DOI: 10.20517/mtod.2025.161 24 Dec 2025
Views: Downloads:
Download PDF

Associations of estimated pulse wave velocity with cardiovascular-kidney-metabolic syndrome in U.S. adults: the role of sex and ethnicity (NHANES 1999-2018)

Open Access Original Article DOI: 10.20517/mtod.2025.159 23 Dec 2025
Views: Downloads:
Download PDF

Medium-chain phosphatidylcholine (MCPC) as a putative option for suppressing hepatocellular inflammation in cholestatic conditions and steatotic liver diseases

Open Access Review DOI: 10.20517/mtod.2025.158 21 Dec 2025
Views: Downloads:
Download PDF

The cumulative effect and sensitive period of overweight/obesity on high blood pressure in children based on the Tianjin Birth Cohort Study

Open Access Original Article DOI: 10.20517/mtod.2025.95 18 Dec 2025
Views: Downloads:
Download PDF

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Open Access Review DOI: 10.20517/mtod.2022.23 30 Jan 2023
Views: Downloads:
Download PDF

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Open Access Review DOI: 10.20517/mtod.2022.38 30 Mar 2023
Views: Downloads:
Download PDF

MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?

Open Access Perspective DOI: 10.20517/mtod.2024.06 26 Feb 2024
Views: Downloads:
Download PDF

Coming soon.

59 Editorial Board Members of Metabolism and Target Organ Damage Named among World's Top 2% of Scientists for 2025
An Impressive Debut with an IF of 3.9, Officially Ranked in Q2
Replay now available - uncover key perspectives from leading experts.
On MASLD Mechanisms, Copper-Based Therapies, and the Future of Liver Disease Management.
Replay now available - uncover key perspectives from leading experts.

Coming soon.

Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/